-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 10, Renfu Pharmaceutical announced that its holding subsidiary, Yichang Renfu, had recently received the "Drug Clinical Trial Approval Letter" approved and issued by the State Drug Administration for acetaminophen and oxycodone sustained-release tablets.
clinical trials of the product for moderate to severe pain
.
Paracetamol and Oxycodone Sustained-Release Tablets is an improvement on the existing immediate-release tablets of Paracetamol and Oxycodone Tablets.
compound tablets
.
At present, there is no product of the same type on the market at home and abroad.